The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Macrophage Polarization Comes of Age
Open accessAbstract
Functional polarization of macrophages into M1 or M2 cells is an operationally useful, simplified conceptual framework describing the plasticity of mononuclear phagocytes. Genetic approaches have begun to shed new light on mechanisms underlying macrophage polarization and on the actual in vivo significance of polarized M2 cells ( [this issue of Immunity]).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, M2 macrophages are involved in polarized Th2 inflammatory reactions and characterized by expression of arginase-1 and mannose and scavenger receptors [19], [20].”
From Rac2 Controls Tumor Growth, Metastasis and M1-M2 Macrophage Differentiation In Vivo (2014) · cites this paper as [19]
In the citing paper
“M1 macrophages are IL-12high, IL-23high, IL-10low; produce high levels of inducible nitric oxide synthetase (iNOS); secrete inflammatory cytokines such as IL-1β, IL-6, and TNF; and are inducer and effector cells in Th1 type inflammatory responses [19].”
From Rac2 Controls Tumor Growth, Metastasis and M1-M2 Macrophage Differentiation In Vivo (2014) · cites this paper as [19]
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Self-citationAlternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Research works printed but not linked: 10
- Dinarello, 2005, Blocking IL-1 in systemic inflammation, J. Exp. Med., 201, 1355, 10.1084/jem.20050640 · DOI
- Duffield, 2005, Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair, J. Clin. Invest., 115, 56, 10.1172/JCI200522675 · DOI · Paper page
- Fang, 2004, Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP, J. Immunol., 173, 360, 10.4049/jimmunol.173.1.360 · DOI
- Herbert, 2004, Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology, Immunity, 20, 623, 10.1016/S1074-7613(04)00107-4 · DOI
- Mantovani, 2002, Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes, Trends Immunol., 23, 549, 10.1016/S1471-4906(02)02302-5 · DOI · Paper page
- Noel, 2004, Alternatively activated macrophages during parasite infections, Trends Parasitol., 20, 126, 10.1016/j.pt.2004.01.004 · DOI
- Pull, 2005, Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury, Proc. Natl. Acad. Sci. USA, 102, 99, 10.1073/pnas.0405979102 · DOI
- Rauh, 2005, SHIP represses the generation of alternatively activated macrophages, Immunity, 24, 361, 10.1016/j.immuni.2005.09.003 · DOI
- Scotton, 2005, Transcriptional profiling reveals complex regulation of the monocyte IL-1 beta system by IL-13, J. Immunol., 174, 834, 10.4049/jimmunol.174.2.834 · DOI
- Zhu, 2004, Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation, Science, 304, 1678, 10.1126/science.1095336 · DOI
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Now We Know Who You Are: A Clear Description of Mononuclear Phagocyte Subsets in the Human Lung.
Singh, D., & Donnelly, L. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201511-2212ed · Cited by 6
Liu, Q., Ma, J., Wang, X., Xiao, F., Li, L., Zhang, J., Lin, Y., Du, C., He, X., Wang, X., et al. (2016) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2016.01.006 · Cited by 7
“Furthermore, IFN-␥ stimulates functional polarization of monocyte-derived macrophages into the classical M1 cells, which express high levels of pro-inflammatory cytokines and provide protection from viral and microbial infections (Mantovani et al., 2004; Mantovani et al., 2005) .”
BackgroundRelaxin: A missing link in the pathomechanisms of Systemic Lupus Erythematosus?
Perumal, M. B., & Dhanasekaran, S. (2014) · Modern Rheumatology · doi:10.3109/14397595.2013.844297 · Cited by 6
Wei, Y.-T., Xia, D.-S., Yang, W., Wang, X., Chen, X., & Dong, N. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914070086 · Cited by 5
Neuroinflammation and Neurodegeneration
Peterson, P. K., & Toborek, M. (2014) · Springer: New York · doi:10.1007/978-1-4939-1071-7 · Cited by 6
Lipid Inflammatory Mediators in Cancer Progression and Therapy.
Khadge, S., Sharp, J., Mcguire, T., Thiele, G. M., & Talmadge, J. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-67577-0_10 · Cited by 6
The M1/M2 Pattern and the Oxidative Stress are Modulated by Low- Level Laser in Human Macrophage
Carvalho, J. L., & Britto, A. (2016) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000387 · Cited by 4
“In addition it is able to secrete pro-inflammatory mediators such as TNF, IL-1β, IL-6 and nitric oxide [4,5].”
Chakraborty, K., Bose, A., Goswami, K., Mukherjee, K., Goswami, S., Ghosh, D., Chakraborty, T., Sarkar, K., Pal, S., Bhowmick, A., et al. (2012) · Human Immunology · doi:10.1016/j.humimm.2011.10.015 · Cited by 6
Hu, Y., Li, H., He, G., Li, X., Hu, J., & Jiang, P. (2025) · Small · doi:10.1002/smll.202411121 · Cited by 4
Wu, H., Wu, Z., Ye, D., Li, H., Dai, Y., Wang, Z., Bao, J., Xu, Y., He, X., Wang, X., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1246880 · Cited by 7
“Tumor-associated macrophages (TAMs) are considered essential tumor-associated immune cells by promoting tumor growth, invasion, and metastasis, which contain two subtypes with separate functions (50).”
Backgroundda Silva, T. B., Rendra, E., David, C., Bieback, K., Cross, M. J., Wilm, B., Liptrott, N., & Murray, P. (2023) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2023.115624 · Cited by 5
Endothelial Progenitor Cells and Macrophage Subsets Recruitment in Postischemic Mouse Hind Limbs
Lamin, V., Mani, A. M., Singh, M. V., & Dokun, A. O. (2023) · Journal of Vascular Research · doi:10.1159/000530732 · Cited by 3
Arif, A. A., Huang, Y.-H., Freeman, S. A., Atif, J., Dean, P., Lai, J. C. Y., Blanchet, M., Wiegand, K. C., McNagny, K. M., Underhill, T. M., et al. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0009 · Cited by 9
“Arginase-1, a marker identified in alternatively activated M2 macrophages (31), also appeared in the BLM-induced immune infiltrates.”
BackgroundStarzl, R., Wolfram, D., Zamora, R., Jefferson, B. S., Barclay, D. A., Ho, C., Gorantla, V. S., Brandacher, G., Schneeberger, S., Lee, W. P. A., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00587 · Cited by 6
“Another prominent cytokine observed in our studies was IL-4, which is known to stimulate IgE B cell differentiation as well as alternative activation of macrophages into M2 repair cells (97), suggesting that IL-4 may be supporting a wound-healing pattern in the “injury group.”
BackgroundKawashima, R., Kawamura, Y. I., Oshio, T., Mizutani, N., Okada, T., Kawamura, Y., Konishi, F., & Dohi, T. (2012) · Journal of immunoassay & immunochemistry · doi:10.1080/15321819.2011.638409 · Cited by 5
“IL-13 may induce alternative (M2 type) activation of macrophages,([15]) and M2 type macrophages have reduced abilities to stimulate T cell proliferation and Th1 differentiation, with the production of large amounts of IL-10.”
Wijesurendra, R. S., Jefferson, A., & Choudhury, R. P. (2010) · Integrative Biology · doi:10.1039/c0ib00022a · Cited by 6
Riquelme, P., Wundt, J., Hutchinson, J. A., Brulport, M., Jun, Y., Sotnikova, A., Girreser, U., Braun, F., Gövert, F., Soria, B., et al. (2009) · Differentiation · doi:10.1016/j.diff.2008.10.008 · Cited by 3
“The macrophage is a very versatile effector cell, which is reflected by the phenotypic diversity of macrophage populations (Grage-Griebenow et al., 2001; Stout and Suttles, 2004; Gordon and Taylor, 2005; Mantovani et al., 2005).”
BackgroundBenzenediamine analog FC-99 inhibits TLR2 and TLR4 signaling in peritoneal macrophage in vitro
Yang, L., Dou, H., Song, Y., & Hou, Y. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.11.023 · Cited by 5
Immunoregulatory cells of the tumor microenvironment.
Chatten, C., & Bathe, O. (2010) · Frontiers in Bioscience · doi:10.2741/3621 · Cited by 5
“A. Sica, A. Saccani, B. Bottazzi, N. Polentarutti, A. Vecchi, J. van Damme and A. Mantovani: Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages.”
ResultInfluentialMacrophages and Tumor Development
Ostrand‐Rosenberg, S., & Sinha, P. (2007) · Springer eBooks · doi:10.1007/978-0-387-69118-3_7 · Cited by 6
Wei, X., Lyu, F., Jia, F., Zhang, L., Zhang, M., Xu, Q., & Hua, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1714761 · Cited by 3
The role of macrophages in vascular calcification: strategies for diagnosis and treatment
Sheng, Y., Qiu, Y., Wang, X., Shi, J., Yin, Z., Zhang, Z., Jiang, S., Zhang, J., Hu, X., & Hong, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1724464 · Cited by 4
Theodoropoulou, T., Mourouzis, I. S., Katsaouni, A., Pantos, C. I., Tsioufis, K. P., & Toutouzas, K. P. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177985 · Cited by 4
Iwanaga, R., Yamamoto, T. M., Gomez, K., Nguyen, L. L., Woodruff, E. R., Post, M. D., Mikeska, R. G., Danis, E. P., Danhorn, T., Boorgula, M. P., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0027 · Cited by 5
“…tumor microenvironment (TME), M1 macrophages are proposed to be tumor-suppressive and M2 macrophages tumor-promoting; however, the expression of M1 and M2 protein markers is not mutually exclusive for each type and the complexity of this spectrum remains a significant focus in the field (39–41).”
BackgroundASK1 activation in glial cells in post‐mortem multiple sclerosis tissue
Seki, E., Guo, X., Namekata, K., Komori, T., Hayashi, H., Arai, N., & Harada, T. (2024) · Neuropathology · doi:10.1111/neup.12978 · Cited by 4
“23,24 We have shown that ASK1 promotes a proin fl ammatory phenotype in microglia/macrophages in EAE mice.”
Ntampakis, G., Pramateftakis, M., Ioannidis, O., Bitsianis, S., Christidis, P., Symeonidis, S., Koliakos, G., Karakota, M., Bekiari, C., Tsakona, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196336 · Cited by 4
Egoraeva, A. A., Tyrtyshnaia, A. A., Ponomarenko, A. I., Ivashkevich, D., Sultanov, R. M., & Manzhulo, I. (2023) · Inflammation · doi:10.1007/s10753-023-01879-2 · Cited by 4
“M2-type macrophages provide the process of apoptotic cell phagocytosis, promote tissue repair and wound healing, have proangiogenic and profibrotic properties [23], reduce inflammation, and stimulate the remodeling of damaged tissues [22, 32].”
BackgroundLi, Z.-F., Yuan, F., Liu, X., Wei, J.-M., Liu, T., Li, W.-D., & Li, C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1201616 · Cited by 4
“M1 macrophages secrete large amounts of proinflammatory factors and tumor necrosis factors to play the biological functions of promoting inflammation and inhibiting cancer (40).”
BackgroundTracers progress for positron emission tomography imaging of glial-related disease
Jia, H., & Xie, T. (2022) · Journal of Biomedical Research · doi:10.7555/jbr.36.20220017 · Cited by 4
Recent advances in targeted drug delivery for the treatment of pancreatic ductal adenocarcinoma
Song, H., & Jiang, C. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2045943 · Cited by 4
Giusti, P., Frascaroli, G., Tammik, C., Gredmark-Russ, S., Söderberg-Nauclér, C., & Varani, S. (2011) · Immunobiology · doi:10.1016/j.imbio.2010.04.004 · Cited by 4
Luo, B., Wu, Z., Hu, C., Ni, A., He, J., Liu, H. B., Xie, W., Li, F., & Gong, W. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70729 · Cited by 3
“16,17 During the acute phase of transplantation, M1 macrophages are particularly important, as they significantly contribute to immune rejection by activating endothelial cells and promoting T cell responses.”
Jiang, L.-Z., Li, C.-Q., Teng, P., Qin, Y., Tang, J.-H., Hu, X.-H., Li, Y.-N., Qin, F.-Y., Yao, S., Qi, X.-W., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-09007-2 · Cited by 3
Zhang, Y., Wang, X., Cao, S., Liu, Y., & Xu, J. (2026) · Inflammation Research · doi:10.1007/s00011-025-02156-8 · Cited by 4
“In contrast, the M2 subset, induced by interleukin-4 (IL4)/ IL-13, is involved in anti-inflammatory activity and tissue healing [10 – 12 ].”
Unraveling the RKIP–YY1 axis: immune crosstalk in the pathogenesis of metabolic disorders
Alzaïd, F., Arefanian, H., Bahman, F., Albeloushi, S., Alhamar, G., Mohammad, A., Hasan, A., Madhoun, A. S. A., Ahmad, R., & Al‐Mulla, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1675699 · Cited by 3
Chen, Y., Zhang, Q., Xie, W., Gao, P., Hu, Z., Wu, S., Bi, Z., Zhang, H., Gao, Y., Wang, C., et al. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114711 · Cited by 4
CFIm25-Dependent Alternative Polyadenylation in AKT2 mRNA Programs Macrophage Polarization
Mukherjee, S., Barua, A., Naseri, M., & Moore, C. L. (2025) · bioRxiv · doi:10.1101/2025.06.19.660629 · Cited by 3
Wang, Y., Liang, J., Yang, C., Wang, J., Zhu, Q., Tong, G., Li, T., Li, G., Huang, Y., Yang, Y., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70425 · Cited by 6
Effect of Fibroblast Signaling on Macrophage Polarization
LoPresti, S. T., Kulkarni, M. M., Julian, D. R., Johnson, Z. I., Lantonio, B. L., Ismail, N., Yates, C. C., & Brown, B. N. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.04.002 · Cited by 5
Zhen, Y.-H., Li, D., Meng, Y., Xing, Z., & Zheng, J. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116911 · Cited by 3
Duraisamy, P., Ravi, S., Martin, L. C., Kumaresan, M., Manikandan, B., & Ramar, M. (2024) · Microscopy research and technique (Print) · doi:10.1002/jemt.24647 · Cited by 3
“…are ever so often believed to be more pro-inflammatory and microbicidal, whereas activated M2 macrophages are predominantly anti-inflammatory and involved in repair functions that exhibit their phenotypic characteristic in immune functions, primarily phagocytosis (Mantovani et al., 2005).”
Wang, M.-J., Song, Y., Guo, X.-Q., Wei, D., Cao, X., Sun, Y., Xu, Y.-G., & Hu, X.-M. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s364414 · Cited by 3
“M1-like macrophages promote inflammation and inhibit the formation of megakaryocytes, whereas M2-like macrophages counter inflammation and promote megakaryocyte formation.(10,11) The balance of M1 and M2 plays a key role in maintaining normal immune function, and has been proven to participate in the pathogenesis of I…”
BackgroundAlahakoon, T. I., Medbury, H., Williams, H., Fewings, N., Wang, X. M., & Lee, V. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology: X · doi:10.1016/j.eurox.2019.100024 · Cited by 3
Plasticité des cellules cancéreuses et dissémination métastatique
Moyret-Lalle, C., Pommier, R. M., Bouard, C., Nouri, E., Richard, G., & Puisieux, A. (2016) · doi:10.1051/medsci/20163208020 · Cited by 3
Chen, T., Lin, C.-C., Huang, P.-T., & Wen, C. (2016) · Tumor Biology · doi:10.1007/s13277-015-4593-6 · Cited by 3
Overcoming Therapeutic Resistance by Targeting Cancer Inflammation
Beatty, G. L. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_158948 · Cited by 7
Kent, D. L. (2015) · Eye · doi:10.1038/eye.2015.140 · Cited by 3
Le trophoblaste : chef d’orchestre de la tolérance immunologique maternelle
Mesdag, V., Salzet, M., & Vinatier, D. (2014) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2014.06.008 · Cited by 4
“Les macrophages M2, qui produisent des antagonistes de l’IL-1 et des prostaglandines PgE2, ont des propriétés immunosuppressives et participent aux différentes activités biologiques comme la conclusion de l’inflammation, le nettoyage des débris cellulaires, la réparation tissulaire et l’angiogenèse [40].”
BackgroundNapoli, M. D., Smith, C. J., Hopkins, S. J., Popa‐Wagner, A., Bugă, A. M., & SLEVIN, M. A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1071-7_11 · Cited by 1
“They produce proinfl ammatory cytokines (IL-1β, IL-12, IL-23, and TNF), chemokines, ROS, and NO, thus promoting a T helper type 1 (Th1) immune response (M1 macrophages), or produce anti-infl ammatory cytokines (IL-10 and TGF-β), IL-1ra, and arginase (M2 macrophages ) [ 92 ].”
BackgroundWang, X., Li, Y., Xiao, H., Zhang, X., Cao, J., Zhang, D., Zhang, J., Li, X., Shen, B., Wang, Q., et al. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12133 · Cited by 2
AdR1-TG/TALLYHO mice have improved lipid accumulation and insulin sensitivity
Luo, N., Wang, X., Zhang, W., Garvey, W. T., & Fu, Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.030 · Cited by 4
Natural Helper Cells and TH2-Type Innate Immunity
Koyasu, S. (2012) · Cornea · doi:10.1097/ico.0b013e318269cb1a · Cited by 4
Chen, H.-D., Cai, H.-L., Chen, L., Wu, X., & Li, D. (2011) · Clinical and investigative medicine. Medecine clinique et experimentale · doi:10.25011/cim.v34i1.15103 · Cited by 3
“Operationally, two distinct activation states have been de!ned for macrophages: the M1 (or classically activated) and M2 (or alternatively activated) macrophages, each associated with speci!c phenotypes and functions [8-10].”
BackgroundRole of Tumor‐Associated Macrophages (TAM) in Cancer Related Inflammation
Sica, A., & Porta, C. (2010) · doi:10.1002/9780470669891.ch5 · Cited by 2
Immunology of the Testis and Male Reproductive Tract
Hedger, M. P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01112-x · Cited by 6
“…(O’Neill and Dinarello 2000), the formalization of multiple macrophage phenotypes corresponding to the type 1 and 2 helper T (Th) cell subsets (Mantovani et al. 2005), the rehabilitation of suppressor and regulatory T cells (Piccirillo and Thornton 2004), and the identification of new…”
Background5-HT2B Receptor on Macrophages: What for?
Nieto, C., Rayo, I., & Corbí, A. L. (2021) · The Receptors · doi:10.1007/978-3-030-55920-5_6 · Cited by 3
Sunthamala, N., Suebsamran, C., Khruaphet, N., Sankla, N., Janpirom, J., Khankhum, S., Thiwthong, R., & Chuncher, S. (2020) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.14.4.13 · Cited by 5
Immunomodulatory Potential of Mesenchymal Stem Cells on Microglia
Vidyadaran, S., Ramasamy, R., & Seow, H. (2012) · doi:10.1007/978-94-007-2993-3_22 · Cited by 3
Huang, J., Xu, X., Jin, Y., Qiao, L. J., Yu, H., Gao, W., & Li, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1752354 · Cited by 2
“M1 and M2 macrophages can undergo mutual conversion, a process known as macrophage polarization (61, 62).”
A RIG-I targeting nanozyme induces PANoptosis for cancer immunotherapy
Dong, S., Yuan, Y., Cao, H., Zhang, M., Liang, S., Zhang, M., Su, X., Luo, L., Zhao, X., Li, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-72973-w · Cited by 1
“Given that M1-type macrophage polarization is essentialforinitiating antitumorimmuneresponses 48,49 , wenextinvestigatedwhetherHemin-His-Mn-treatedcancercellscould promote M1 polarization (Fig.”
Hongxia, Y., He, J., Niu, J., & Zhou, M. M. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c02184 · Cited by 2
Ma, S.-Q., Cui, M., Chang, K., Yang, G., Li, L., Kou, B., Xu, B., Li, Y., Liu, F., Jin, M., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.102994 · Cited by 2
“…inflammatory responses [51], whereas M2 macrophages express high levels of the mannose receptor (CD206) and release anti-inflammatory factors (e.g., IL-10, and TGF-β ) to promote tissue repair and reduce inflammation [50](IL-10, TGF-β ), which promote tissue repair and reduce inflammation [52].”
Sheng, W., Guo, T., Yu, B., Zhao, J., Hu, C., Lin, J., Weng, J., Chen, Y., Wang, D., Yu, F., et al. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151281 · Cited by 1
Fengmin, C. H. E. N., Yuqi, Z. H. O. U., Feng, Y., & Hongguang, Z. H. U. (2025) · Dental Materials Journal · doi:10.4012/dmj.2025-145 · Cited by 2
Rickert, D. M., Hill, E., Himmelberger, R., Rajbanshi, N., Cardozo, S., de Castro, T. B., Bharadwaj, R., Scott, A. J., Silverman, N. S., Goldman, W. E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.08.669383 · Cited by 5
Li, Q., Liu, Y., Zhang, L., Zheng, Y., Feng, X., & Wang, Y. (2025) · Human Cell · doi:10.1007/s13577-025-01299-4 · Cited by 2
“Anti-tumoral M1-like TAMs induce host defense, immunity reaction, and inflammatory response, while Pro-tumoral M2-like TAMs contribute to tumor progression [8, 9].”
Xu, X.-Y., Yan, M., Xie, Z.-W., Zhang, Y.-Q., Wu, L., Zhang, B.-M., & Jiang, J.-T. (2025) · Translational Cancer Research · doi:10.21037/tcr-24-2013 · Cited by 2
“Although macrophages can polarize into successive phenotypes, they are usually classified as “M1” and “M2” (9).”
Role of Macrophage Polarization in Chronic Rhinosinusitis Based on the Yin-Yang Theory: A Review
Wang, F., Xiong, Y., Zhu, Y., Yang, X., Liu, K., & Zhu, Z. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s514060 · Cited by 2
“13,14 Monocytes in the bone marrow differentiate into macrophages under the influence of macrophage colony-stimulating factor, 15,16 and subsequently enter different tissues through the circulatory system.”
rFIP-nha activates macrophages towards a pro-inflammatory phenotype via AIM2 inflammasome modulation
Liu, Y., Li, Z., Wichers, H., Bastiaan-Net, S., & Hoppenbrouwers, T. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1533742 · Cited by 2
From drosophila to humans: a journey through macrophage development
Doyle, E. H., Vaughan, H. J., & Mariani, S. A. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104272 · Cited by 5
Gu, J., Wang, J., Sun, Y., Mao, X., Qian, C., Tang, X., Ji, W., Xie, H., Ling, L., Zhao, Y., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.6864 · Cited by 4
“43 46 An earlier study by Denkert et al. has shown that increased TILs are associated with a survival benefit in HER2-positive breast cancer or TNBC but are an adverse prognostic factor for survival in lunimal- HER2-negative breast cancer.”
BackgroundCo, I. L., Yu, C., Lamorte, S., Ciudad, M. T., Landon‐Brace, N., Cadavid, J. L., Xia, Z. J., Fomina, A., Nurse, M., McGaha, T. L., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.13.548899 · Cited by 4
miRNAs as key modulators between normal cells and tumor microenvironment interactions
Nour, S. M., Abbasi, N., Sadi, S., Ravan, N., Alipourian, A., Yarizadeh, M., Soofi, A., Ataei, A., & Tehrany, P. M. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14285 · Cited by 3
Chen, C.-C., Wei, H., Song, J., & Zhang, X. (2022) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v21i5.9 · Cited by 2
“Measurement of pro-inflammatory cytokines after elastase treatment indicated up-regulated expressions of IL-1β, IL-6, and TNFα arising from activated macrophages [20].”
BackgroundApolipoprotein E deficiency enhances the anti-tumor immunity via repressing T cell exhaustion
Zhao, B., Wang, W., Chen, Z., & Jin, S. (2021) · All Life · doi:10.1080/26895293.2021.2001382 · Cited by 1
CD11c−MHC2low Macrophages Are a New Inflammatory and Dynamic Subset in Murine Adipose Tissue
Wetzels, S., Bijnen, M., Wijnands, E., van de Gaar, J., Tan, A., Coort, S. L., Biessen, E. A. L., Schalkwijk, C. G., & Wouters, K. (2020) · Immunometabolism · doi:10.20900/immunometab20200015 · Cited by 4
“Canonically, ATMs, like all macrophages, are subdivided in two distinct populations: inflammatory M1 macrophages and antiinflammatory or resolving M2 macrophages [19].”
BackgroundGeneration and characterization of bovine bone marrow‐derived macrophage cell line
Xiao, J., Xie, R.-X., Li, Q.-Q., Chen, W., & Zhang, Y. (2016) · Cell Biology International · doi:10.1002/cbin.10599 · Cited by 2
“Moreover, TERT-bBMMs cells produced the cytokines IL-1b, IL-6, IL-10, IL-12, TNF-a (Figure 2) and macrophage surface antigens CD11b and CD282 (Figure 1B).”
BackgroundInfluentialKondo, Y., Kinoshita, M., Yoshida, T., Matoba, H., Uehara, T., Ikeyama, M., Nakayama, J., Yoshida, K., & Ikeda, S. (2016) · Case Reports in Clinical Medicine · doi:10.4236/crcm.2016.53014 · Cited by 2
“Macrophages are roughly classified into two different subtypes: classically activated (M1)-type and alternatively activated (M2)-type macrophages [6].”
BackgroundWijers, G. V. M. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000292 · Cited by 3
“After differentiation, macrophages retain plasticity and further adapt their functional phenotype in response to micro environmental cues [11], resulting in a continuum of diverse functional states [7].”
BackgroundAl-hassnawi, A., Omran, A., Al-Thaheb, L., Al-Dahmoshi, H., Al-Mammori, R. T., Al-Shareef, H. K., Salman, N., & Al-Khafaji, K. (2014) · doi:10.5923/j.als.20140406.02 · Cited by 2
“Mirroring the Th1/Th2 nomenclature, polarized macrophages are often referred to as M1 (classical activation) and M2 (alternative activation) cells, respectively [8, 9].”
BackgroundBonecchi, R., Savino, B., Pesant, M., & Locati, M. (2012) · InTech eBooks · doi:10.5772/34377 · Cited by 1
“…exhibit cytotoxic activity and high phagocytosis capacity, a high production or reactive oxygen intermediates (ROI), and display a good antigen presentation capability (Mantovani et al. 2002; Gordon 2003; Verreck et al. 2004; Gordon & Taylor 2005; Mantovani et al. 2005; Martinez et al. 2006).”
Self-citationEndotoxin Tolerance as a Key Mechanism for Immunosuppression
Subhra, K., & Irina, N. (2012) · InTech eBooks · doi:10.5772/27368 · Cited by 3
“IL-10), scavenging receptor and efficient phagocytosis (del Fresno et al., 2009; Mantovani et al., 2005).”
Luo, H., Huang, W., Wang, D., Wang, H., & Nie, K. (2011) · BMC Immunology · doi:10.1186/1471-2172-12-63 · Cited by 3
“hepatica induces Th2 responses characterized by increased IL-4, IL-5, and IL-13, activation and expansion of eosinophils, CD4cells, basophils, and mast cells [8-10,13,34-39].”
BackgroundRetractedSerum from morbidly obese patients affects melanoma cell behavior in vitro
Mocellin, D., Bratti, L. D. O. S., Silva, A. H., Assunção, L. S., Kretzer, I. F., & Filippin-Monteiro, F. B. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-979020201000x42e19375 · Cited by 2
Uterine macrophages: Essential roles for a successful human pregnancy
Qi, Y., Ning, F., & Lash, G. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818508-7.00008-7 · Cited by 4
An, G. C., Cockrell, C., Zamora, R., & Yoram Vodovotz, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821440-4.00009-8 · Cited by 4
Microglial Biology and Physiology
Butovsky, O., Madore, C., & Weiner, H. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_13 · Cited by 1
B-Cells in Stroke and Preconditioning-Induced Protection Against Stroke
Selvaraj, U. M., Poinsatte, K., & Stowe, A. M. (2016) · Springer series in translational stroke research · doi:10.1007/978-3-319-32337-4_12 · Cited by 2
Colony stimulating factors and macrophage heterogeneity
Hamilton, J. A. (2011) · Inflammation and Regeneration · doi:10.2492/inflammregen.31.228 · Cited by 2
Brodt, P. (2010) · Cancer metastasis · doi:10.1007/978-90-481-8833-8_10 · Cited by 4
Jeong, J. Y., Yoon, I. S., Jeong, S. W., Nam, H. J., Lee, G. W., & Hong, C. A. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124599 · Cited by 1
Zeng, L., Yang, J., & Yan, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1744464 · Cited by 1
“…categorized into two populations: long-lived resident AMs, which maintain a quiescent, anti-in fl ammatory M2 phenotype under homeostatic conditions, and recruited monocyte-derived AMs, which differentiate into a pro-in fl ammatory M1 phenotype in response to infection and tissue injury (123 – 131).”
Kizhakkanoodan, K. S., Inigo, V. J., Laxminarayana, S. L. K., Seetharam, R. N., Guruprasad, K. P., & Guru, B. R. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02190-8 · Cited by 1
Kalshetti, D., Amin, M., Varsani, R., Narayanan, A., Ciurca, S., Grijalva, I., Lickfeld, A., Lukan, J. K., Schwaitzberg, S. D., & Arany, P. (2026) · Advances in Wound Care · doi:10.1177/21621918261450363 · Cited by 1
Wan, Z., & Ding, Y.-C. (2026) · Immunologic research · doi:10.1007/s12026-026-09765-3 · Cited by 1
CFIm25-dependent alternative polyadenylation in AKT2 mRNA programs macrophage polarization
Mukherjee, S., Barua, A., Naseri, M., & Moore, C. L. (2026) · iScience · doi:10.1016/j.isci.2026.115791 · Cited by 2
A Comprehensive Review on the Immune System and Immune Therapy in Liver Cancer and Colorectal Cancer
Alam, F., Ghosh, A., Sen, A., Dey, D., Ghora, S. S., Guchhait, S., Pandey, P., Dutta, A., & Chakraborty, P. (2026) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3339 · Cited by 1
Li, J., Wang, Y., Liu, J.-F., Wang, N.-N., Shen, P., Zhou, W., Bai, Z.-J., & Gao, Y. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158122 · Cited by 1
de Moraes, F. C. A., Wagner, P. H. D. S., Rd, H., Burbano, R. M. R., & Hirata, M. H. (2026) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2026.2617952 · Cited by 1
Kim, S., Han, I., Lee, S., Park, S., Jeon, J.-W., & Bae, H. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1698857 · Cited by 1
Metadata
- Authors
- Mantovani, Sica, & Locati, M.
- Affiliations
- University of Milan (IT)
- Corresponding author
- Mantovani,, Alberto
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2005-10
- Volume
- 23
- Issue
- 4
- Pages
- 344-346
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W1986736465
- Cited by
- 1,259
- References
- 0
- Citations by year
- 2026: 41 · 2025: 60 · 2024: 58 · 2023: 54 · 2022: 70 · 2021: 65 · 2020: 68 · 2019: 58 · 2018: 57 · 2017: 70 · 2016: 67 · 2015: 64 · 2014: 85 · 2013: 89 · 2012: 80
- FWCI
- 9.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2846 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Associazione Italiana per la Ricerca sul Cancro
- European Commission
- Ministero della Salute
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- macrophage polarization, M1 macrophages, M2 macrophages, mononuclear phagocytes, macrophage plasticity
- MeSH terms
- Cell Differentiation, Macrophages
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review